Ipsen SA M&A Call Transcript
Hello, and welcome to the Ipsen conference call and webcast on acquisition of Albireo.
I now hand you over to David Loew, Ipsen's CEO. Please go ahead, sir.
Thank you, operator. Good afternoon or good morning, everyone. As you just heard, I'm David Loew, Chief Executive of Ipsen. We're live at the JPMorgan Healthcare Conference in San Francisco, and I'm delighted that you have joined us today as we take you through today's exciting news on the acquisition of Albireo.
Please turn to Slide 2. This is our usual safe harbor statements which outlines the routine risks and uncertainties contained within this presentation.
Please turn to Slide 3. I'm joined today by Howard Mayer, Ipsen's Head of Research & Development; as well as our CFO, Aymeric Le Chatelier. We'll provide a brief presentation before using the majority of the time to answer your questions.
Please turn to Slide 4. I will begin the presentation by taking you through the strategic rationale for the acquisition. I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |